Description
Compound Development Team Leader (CDTL) - Autoantibody, Immunology
Janssen Research and Development, L.L.C., a member of Johnson and Johnson's Family of Companies, is recruiting for a Compound Development Team Leader (CDTL), to be located in San Diego, CA; Boston, MA; or Spring House, PA. Remote work options may be considered on a case-by-case basis and if approved by the Company.
At the Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found.
As Immunology Leaders, we know immunology is vital to human health. Driven by a relentless focus on patient unmet needs, we will redefine treatments for immune diseases by delivering transformational and accessible therapies and regimens to patients with immune-mediated disease. For more than two decades we have been a world leader in the development of transformational medicines, establishing one of the strongest, first-in-class portfolios and pipelines in the industry, including the first tumor necrosis factor (TNF) inhibitor, and first interleukin (IL)-12 and IL-23 inhibitors. We tirelessly push the boundaries of science and creativity, applying our deep disease insights, novel pathway science, new technologies, and treatment modalities to restore immune homeostasis.
Janssen Research & Development, LLC. discovers and develops innovative medical solutions to address important unmet medical needs in the following therapeutic areas: immunology, oncology, neuroscience, infectious diseases & vaccines, cardiovascular & metabolism, and pulmonary hypertension. Please visit for more information.
We are J&J. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it. We are guided by our Credo.
Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion. Proud to be an equal opportunity employer.
The early Compound Development Team Leader (CDTL) will work within the Autoantibody team focused on the early portfolio and molecular differentiation. The CDTL will partner closely with the Portfolio & Asset Management organization as part of the wider CDTL community. They will lead a cross-functional compound development team to maximize the value of the asset and drives execution of the compound strategy. The CDTL champions the project(s) at all levels of J&J through providing clear communication, creative strategic approaches to development and securing appropriate resources to deliver on the milestones. They will also integrate the molecular differentiation work across the portfolio.
The eCDTL leads a cross-functional matrix compound development team to deliver against the asset strategy. Beginning at Lead Optimization entry the eCDTL drives the development and execution of the compound strategy, working in close partnership with the Discovery Project Leader. The eCDTL becomes the sole project team leader at New Molecular Entity Designation.
Responsibilities include but are not limited to:
Lead the development and execution of the compound development strategy for multiple programs, creating a vision for each compound within the TA portfolio, including identifying potential indication to be pursued and sequencing of these indications.
Assembles and leads an early CDT with representation from appropriate functional partners, for the creation of a Development Plan that provides a thorough and clear asset strategy, integrating input from all functional areas, identifying key development issues and the strategic approach to each, with associated timelines and budgets, offering clarity on alternative pathways and tradeoffs considered.
o Creates the target product profile in collaboration with commercial, market access and clinical groups, and adjust this profile as new information and insights are gained
o Drives decision-making on compound strategy, ensuring relevant research, analysis, and expertise are taken into account.
o Leads discussions at the CDT to reach decisions, including making final decisions when full consensus cannot be reached.
o Challenges functional representatives to ensure that all issues and questions are being addressed, and that functional area input into the strategy is adequate to meet the needs of the compound
o Manages the complexity of internal/external development activities and proactively identifies issues and risks while leading contingency planning and problem solving at early stages of development.
o Ensures development and implementation of optimal IP, publication and regulatory strategies to protect and maximize asset value.
o Collaborates closely with the PML on the asset to plan fit-for-purpose resources (FTEs and budget) to deliver the program and ensure adequate project resource utilization and budget management, providing clarity and transparency on changes and potential tradeoffs.
o Mentors and coaches assigned team members to lead sub-teams and other Early Development Programs as required.
Ensures alignment with Leadership and executes on feedback with regard to Go/NoGo decisions, timelines, key studies, resource allocations and budgets, valuations and prioritization.
Present strategic options and champion phase transition proposals at governance boards
Focuses on overall asset and pipeline value rather than single project value - can balance role as team leader with commitment to maximizing portfolio value - willing to support Go decisions and appropriately come to NoGo decisions
Plays an active role as a member of the CDTL community to help lead and devise strategies for key strategic initiatives and talent development across the Portfolio.
Represents the CDT on various cross functional committees.
Leads cross functional/therapeutic area/company initiatives outside of CDT.
Participates in portfolio/strategy committees within the DAS/TA.
Capabilities:
Deep understanding of the unmet need addressed by the asset; scientific/disease areas expertise as well as expertise in current and innovative therapeutic development paradigms
Ability to integrate all cross functional disciplines into a successful strategy
Strong problem-solving skills for developing creative solutions and meeting project objectives
Influence, negotiation and conflict resolution skills, including the ability to influence without clear reporting authority
Ability to identify and manage all stakeholders, including at the most senior levels in the organization
Demonstrated ability of strategic thinking and contingency planning
Deep understanding of requirements for successful commercialization of a new product, including competitive and payer landscape across different geographies and pricing strategies
Strategic Agility: Understanding big picture for compound and Janssen portfolio, translating scientific and business concepts into short and long-term deliverables, managing ambiguity and making decisions with incomplete data
Qualifications
Advanced Degree (Ph.D., M.D., or Pharm.D.,) is preferred
At least 10 years of pharmaceutical industry experience is preferred
Experience in a leadership role as part of a research-driven pharmaceutical company is required
Experience in cross-functional team leadership, including strategy development and driving tactical delivery of programs is required
Experience in influence, negotiation and conflict resolution skills, including the ability to influence without reporting authority are required
Outstanding leadership and communication skills are required
Experience with drug development in Immunology is preferred (experience in early development in preferred)
Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
The anticipated base pay range for this position is $238,000 to $322,000.

Employers have access to artificial intelligence language tools (“AI”) that help generate and enhance job descriptions and AI may have been used to create this description. The position description has been reviewed for accuracy and Dice believes it to correctly reflect the job opportunity.